Business · 07/08/2017Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Oncologic Drugs Advisory Committee for Public Comment
Summary
The US Food and Drug Administration (FDA) is hosting a public meeting of its Oncologic Drugs Advisory Committee to gather input on regulatory issues, with a public docket open for comments on the meeting and its agenda.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →